本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ovid Therapeutics Inc.

0.6185
-0.0745-10.75%
盤後0.6156-0.0029-0.47%19:58 EDT
成交量:108.30萬
成交額:68.78萬
市值:4,398.12萬
市盈率:-1.80
高:0.6999
開:0.6997
低:0.6097
收:0.6930
資料載入中...
2020/07/13

重要事件披露

8-K - Current report
2020/06/19

重要事件披露

8-K - Current report
2020/06/17

重要事件披露

8-K - Current report
2020/06/05

重要事件披露

8-K - Current report
2020/05/27

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/13

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/07

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/05/07

重要事件披露

Current report, items 2.02, 8.01, and 9.01
2020/03/30

重要事件披露

Current report, items 8.01 and 9.01
2020/03/27

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/03/13

重要事件披露

Current report, items 7.01 and 9.01
2020/03/11

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/03/11

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/11

重要事件披露

Current report, items 2.02 and 9.01
2020/03/02

重要事件披露

Current report, items 7.01 and 9.01
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals